Literature DB >> 9467724

Risk factors, causality, and policy initiatives: the case of aluminum and mental impairment.

W F Forbes1, J F Gentleman.   

Abstract

The question addressed is when can the evidence concerning a health issue be regarded as adequate to implement policy initiatives. The approach is illustrated by comparing evidence about the effects of cigarette smoking with evidence for the aluminum (Al) hypothesis (that Al contributes to mental impairment and especially to Alzheimer's Disease). The criteria for evaluating the evidence are based on the consistency and strength of the association between a putative risk factor and the relevant outcome variable, the likelihood that the relative risk represents a causal relationship, whether possible mechanisms are available, the number of persons affected, and the costs of modifying the risk factor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9467724     DOI: 10.1016/s0531-5565(97)00061-2

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  9 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

Review 2.  Calcium silicate-based cements and functional impacts of various constituents.

Authors:  Mohammad Ali Saghiri; Jafar Orangi; Armen Asatourian; James L Gutmann; Franklin Garcia-Godoy; Mehrdad Lotfi; Nader Sheibani
Journal:  Dent Mater J       Date:  2016-10-22       Impact factor: 2.102

3.  An investigation into the structure and reactivity of calcium-zinc-silicate ionomer glasses using MAS-NMR spectroscopy.

Authors:  D Boyd; M R Towler; R V Law; R G Hill
Journal:  J Mater Sci Mater Med       Date:  2006-05       Impact factor: 3.896

4.  Characterization of un-hydrated and hydrated BioAggregate™ and MTA Angelus™.

Authors:  J Camilleri; F Sorrentino; D Damidot
Journal:  Clin Oral Investig       Date:  2014-08-01       Impact factor: 3.573

5.  Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease.

Authors:  W J Lukiw; H J LeBlanc; L A Carver; D R McLachlan; N G Bazan
Journal:  J Mol Neurosci       Date:  1998-08       Impact factor: 3.444

6.  Development of novel tricalcium silicate-based endodontic cements with sintered radiopacifier phase.

Authors:  M Xuereb; F Sorrentino; D Damidot; Josette Camilleri
Journal:  Clin Oral Investig       Date:  2015-09-01       Impact factor: 3.573

7.  The role of Sr2+ on the structure and reactivity of SrO-CaO-ZnO-SiO2 ionomer glasses.

Authors:  Daniel Boyd; Mark R Towler; Sally Watts; Robert G Hill; Anthony W Wren; Owen M Clarkin
Journal:  J Mater Sci Mater Med       Date:  2007-08-01       Impact factor: 3.896

8.  Incorporating Germanium Oxide into the Glass Phase of Novel Zinc/Magnesium-Based GPCs Designed for Bone Void Filling: Evaluating Their Physical and Mechanical Properties.

Authors:  Basel A Khader; Omar Rodriguez; Mark R Towler
Journal:  J Funct Biomater       Date:  2018-07-31

9.  X-ray diffraction analysis of MTA-Plus, MTA-Angelus and DiaRoot BioAggregate.

Authors:  Yeliz Guven; Elif Bahar Tuna; Muzaffer Emin Dincol; Oya Aktoren
Journal:  Eur J Dent       Date:  2014-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.